NDC Package 73606-020-01 Syfovre

Pegcetacoplan Injection, Solution Intravitreal - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
73606-020-01
Package Description:
1 VIAL, GLASS in 1 CARTON / 3 mL in 1 VIAL, GLASS
Product Code:
Proprietary Name:
Syfovre
Non-Proprietary Name:
Pegcetacoplan
Substance Name:
Pegcetacoplan
Usage Information:
SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
11-Digit NDC Billing Format:
73606002001
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2630847 - pegcetacoplan 15 MG in 0.1 ML Injection
  • RxCUI: 2630847 - 0.1 ML pegcetacoplan 150 MG/ML Injection
  • RxCUI: 2630847 - pegcetacoplan 15 MG per 0.1 ML Injection
  • RxCUI: 2630853 - SYFOVRE 15 MG in 0.1 ML Injection
  • RxCUI: 2630853 - 0.1 ML pegcetacoplan 150 MG/ML Injection [Syfovre]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Apellis Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravitreal - Administration within the vitreous body of the eye.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA217171
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    02-17-2023
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 73606-020-01?

    The NDC Packaged Code 73606-020-01 is assigned to a package of 1 vial, glass in 1 carton / 3 ml in 1 vial, glass of Syfovre, a human prescription drug labeled by Apellis Pharmaceuticals, Inc.. The product's dosage form is injection, solution and is administered via intravitreal form.

    Is NDC 73606-020 included in the NDC Directory?

    Yes, Syfovre with product code 73606-020 is active and included in the NDC Directory. The product was first marketed by Apellis Pharmaceuticals, Inc. on February 17, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 73606-020-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 73606-020-01?

    The 11-digit format is 73606002001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-273606-020-015-4-273606-0020-01